Jubilant Pharmova informs about closure of manufacturing operations

18 Apr 2024 Evaluate

Jubilant Pharmova has informed that the Company’s subsidiary Jubilant Cadista Pharmaceuticals Inc., USA (‘Jubilant Cadista’) has decided to close the manufacturing operations of its solid dosage formulation facility at Salisbury, Maryland, USA. The expected date of cessation of manufacturing operation and first separations at the said facility will be on June 17, 2024. Jubilant Cadista will continue the sales and marketing operations for US market. The said facility manufactures tablets and capsules for the US market and has the capacity to serve 1.5 billion doses.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

679.35 -7.00 (-1.02%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.